Skip to search formSkip to main contentSkip to account menu

CMI 392

Known as: CMI-392 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

FuransLipoxygenase InhibitorsUrea
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Synthesis of (.+‐.)‐trans‐2‐ [3‐Methoxy‐4‐(4‐chlorophenylthioethoxy)‐5‐cyanophenyl] ‐5‐(3,4,5‐trimethoxyphenyl)tetrahydrofuran.
The synthesis of a potent platelet activating factor is described utilising commercially available acetovanillone and ethyl 3,4,5… 
1998
1998
(+/-)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and…
By incorporating an N-hydroxyurea functionality onto diaryltetrahydrofurans, a novel series of compounds was investigated as dual… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)